Delcath Systems Inc.
Clinical trials sponsored by Delcath Systems Inc., explained in plain language.
-
New combo targets liver tumors in hard-to-treat colorectal cancer
Disease control Recruiting nowThis study tests whether giving a strong chemotherapy directly to the liver, followed by standard cancer drugs, works better than the standard drugs alone for people with colorectal cancer that has spread mainly to the liver and is no longer responding to other treatments. About …
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New combo targets liver tumors in advanced breast cancer
Disease control Recruiting nowThis study tests whether giving high-dose chemotherapy directly to the liver, followed by standard cancer pills or infusions, works better than standard treatment alone for people with breast cancer that has spread mainly to the liver. About 90 participants will be randomly assig…
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC